Dose escalation of a curcuminoid formulation
2006

Curcumin Dose Escalation Study

Sample size: 24 publication Evidence: moderate

Author Information

Author(s): Christopher D Lao, Mack T Ruffin IV, Daniel Normolle, Dennis D Heath, Sandra I Murray, Joanne M Bailey, Martha E Boggs, James Crowell, Cheryl L Rock, Dean E Brenner

Primary Institution: University of Michigan

Hypothesis

What is the maximum tolerated dose and safety of curcumin in healthy volunteers?

Conclusion

Curcumin is well-tolerated in high single doses, suggesting its potential as a long-term cancer prevention agent.

Supporting Evidence

  • 30% of participants experienced minimal toxicity.
  • No curcumin was detected in serum for doses up to 8,000 mg.
  • Low levels of curcumin were found only at doses of 10,000 and 12,000 mg.

Takeaway

Curcumin, a spice from turmeric, can be taken in large amounts without causing serious side effects, which is good news for cancer prevention.

Methodology

Healthy volunteers were given escalating doses of curcumin from 500 to 12,000 mg to assess safety and maximum tolerated dose.

Limitations

The study had a small sample size and did not define a maximum tolerated dose.

Participant Demographics

13 men and 11 women, mean age 34 years, predominantly Caucasian.

Digital Object Identifier (DOI)

10.1186/1472-6882-6-10

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication